Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin and corticosteroid for lateral epicondylitis
2017-001709-33Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A and prednisolone in Lateral Epicondylitis (LET) (4 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2017; status: completed.
02
Drugs
botulinum toxin type Aprednisolone
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on 2017-001709-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001709-33.